$MANH

Gantt James Stewart (EVP, Professional Services) sold 5,139 shares of MANHATTAN ASSOCIATES INC (MANH) at $195.53 ($1.00M total) on 2026-07-30.

Manhattan Associates (NASDAQ: MANH) shares rose 22.6% after the company reported Q2 2026 adjusted earnings of $1.39 per share on $297.8 million revenue, beating analyst estimates. The firm raised full-year revenue guidance to a $1.16 billion midpoint and lifted adjusted EPS guidance to $5.47 at the midpoint.

Investing.com reports Wednesday’s stock moves after the Fed held interest rates steady, with three policymakers voting for a hike. Notable decliners include KLA-Tencor (KLAC) -7.69% and Caterpillar (CAT) -6.09%, plus Micron (MU) -4.98% and Applied Materials (AMAT) -4.8%. Lennox (LII) fell 8% after a Q2 revenue miss and guidance cut.

Manhattan Associates (MAnhattan Associates) shares rose 26.7% to $213.07 after the company reported record Q2 results. Revenue was $297.8M, up 9.3% year over year and above consensus of about $293.7M. Cloud subscription revenue grew 26% to $126.7M. Non-GAAP EPS was $1.39 vs $1.34 expected. Remaining performance obligations rose 23% to $2.5B.

U.S. stocks opened lower amid rate-hike jitters and an upcoming tech earnings cycle. Investing.com listed major movers including KLA-Tencor (KLAC -8.07%), Applied Materials (AMAT -5.05%), and Arm (ARM -5.81%). Lennox (LII) fell about 8% after a Q2 revenue miss and reduced guidance, while Teva (TEVA) rose on a Q2 top-line beat.

Manhattan Associates (MANH) reported second-quarter results that beat guidance. The company said revenue rose 9% year over year to $298 million, above guidance of $287 million. Non-GAAP operating margin was 34.9%, versus 34.7% guided.

US equity futures edged higher as S&P 500 and Nasdaq 100 contracts were up about 0.2% premarket, despite a sharp Kospi selloff in Asia and a 5% oil jump. The article cites earnings and guidance moves for several companies, including MSFT and META, plus notable premarket moves: AVTR +4%, BE +8%, CAT -4%, and others. It also notes a Fed decision later today with markets pricing a 32% hike chance.

A roundup of Wall Street analyst actions includes UBS upgrading Weatherford (WFRD) to Buy with a $114 target, KeyBanc initiating Reddit (RDDT) at Overweight with a $225 target, and Mizuho upgrading Lineage (LINE) to Outperform with a $47 target. Citi cut Disney’s target to $135 ahead of earnings, while Evercore reiterated Apple (AAPL) Outperform. Wells Fargo raised Snowflake (SNOW) to $500. Truist reiterated Nvidia (NVDA), AMD (AMD), and Broadcom (AVGO) as buys.

Premarket movers include Biogen (+0.7%) after beating revenue and EPS estimates and raising full-year adjusted EPS guidance; Vertiv (-13%) despite Q2 beats but weaker organic growth; Generac (+5.5%) on Q2 EPS $2.91 vs $2.01 forecast; GE HealthCare (+12%) on Q2 adjusted EPS $1.13 vs $1.04 and reaffirmed 2026 guidance; Visa (-2%) after 2026 guidance missed expectations.

Manhattan Associates (Nasdaq: MANH) introduced Sightline, a new capability in its ActivePlanning software, to explain the drivers behind AI-driven forecasts, recommendations, and inventory decisions in plain language. The company says it provides in-application “why” analysis for factors like safety stock, lead times, vendor minimums, promotions, and network movements.